Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports the completed Phase 2 study evaluating the safety, tolerability, and efficacy of three dose levels of Mitoglitazone in Type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Mitoglitazone

Snippet

Sponsor: Metabolic Solutions Development Company | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2013-03-22